Participants with a history or diagnosis of Behcet's disease (since tapering or withdrawal of concomitant immunosuppressive medications is not a standard of care for Behcet's patients) or a primary diagnosis of anterior uveitis (e.g., juvenile rheumatoid arthritis (JRA) or HLA-B27 associated uveitis, ocular conditions usually treated with local and not systemic medications).